About Helaina
Helaina focuses on advanced nutrition by replicating functional proteins found in the human body to create new nutrients. Its main product, Effera™, is a dietary supplement that mimics Human Lactoferrin, a protein essential for gut health, iron utilization, and immune support. This product allows consumers to access a protein that is naturally present in their bodies, setting Helaina apart from competitors who may not offer such specific bioactive proteins. The goal of Helaina is to enhance vitality and overall health for health-conscious consumers through science-backed nutritional supplements.
New York City, New YorkHeadquarters
2019Year Founded
$67.7MTotal Funding
SERIES_BCompany Stage
Food & Agriculture, HealthcareIndustries
51-200Employees
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Disability Insurance
401(k) Company Match
Unlimited Paid Time Off
Paid Parental Leave
Childcare Support
Commuter Benefits
Leadership Development coaching through BetterUp
Risks
Consumer skepticism towards lab-grown foods could hinder Helaina's market acceptance.
The evolving regulatory landscape may delay necessary approvals for Helaina's products.
High costs of precision fermentation technology may limit product accessibility.
Differentiation
Helaina uses precision fermentation to replicate human milk proteins, offering unique nutritional benefits.
Effera™ is a pioneering product, providing immune and gut health support through lactoferrin.
Helaina's technology platform creates bioactive proteins, setting new standards in advanced nutrition.
Upsides
Helaina raised $45 million in Series B funding to accelerate commercialization of Effera™.
The precision fermentation market is projected to grow significantly, benefiting Helaina's technology.
Growing consumer interest in functional foods aligns with Helaina's product offerings.
Funding
Total raised$67.70 M
Latest valuation$225.00 M
StageSERIES_B
SEED
7/31/2020$4
$20.00 M